Intracranial Hemorrhage

Updated: June 6, 2025

Mail Whatsapp PDF Image

Background

Intracranial hemorrhage occurs in brain or meninges. Meningeal hemorrhage includes epidural, subdural, and subarachnoid types.

Intracerebral hemorrhage causes more death and disability than other strokes. Intracerebral hemorrhage causes edema to disrupt brain tissue and dysfunction.

Brain parenchyma displacement can increase intracranial pressure and herniation

It occurs in various brain areas and is classified into multiple types.

Types of Intracranial Hemorrhage are:

Intracerebral Hemorrhage

Subarachnoid Hemorrhage

Epidural Hemorrhage

Subdural Hemorrhage

Intracranial Hemorrhage is dangerous bleeding inside the skull. Ruptured blood vessel causes accumulation of blood in brain.

It increased intracranial pressure damages brain tissue. Blood products cause inflammation, injury to brain cells, and disrupt cerebral autoregulation.

Epidemiology

Intracerebral hemorrhage affects 12-15 per 100,000 individuals yearly. Asian countries have higher intracerebral hemorrhage incidence globally.

Over 20,000 Americans die annually from intracerebral hemorrhage, with a 30-day mortality rate of 44%.

Intracerebral hemorrhage occurs more in hypertensive African American populations.

Higher intracerebral hemorrhage rates observed in Asian populations may stem from environmental or genetic factors.

Intracerebral hemorrhage slightly favours males, while cerebral amyloid angiopathy may favour females.

Intracerebral hemorrhage incidence doubles every decade after age 55 until 80 years old.

Anatomy

Pathophysiology

Hypertensive damage causes most nontraumatic intracerebral hemorrhages.

Cranial trauma causes intracerebral hemorrhage frequently. Blunt head trauma patients on warfarin or clopidogrel face higher intracranial hemorrhage risk.

Rare delayed traumatic intracranial hemorrhage in warfarin patients. Intraventricular hemorrhage occurs in one-third of intracerebral hemorrhage cases due to extension.

Chronic hypertension leads to small vessel vasculopathy with lipohyalinosis and Charcot-Bouchard aneurysms in brain.

Etiology

The causes of intracranial hemorrhage are:

Vascular Malformations

Tumors

Illicit Drug Use

Vascular disease

Blood disorders

Substance use

Trauma

Infections

Age

Genetics

Prognostic Factors

Anticoagulation during hemorrhage increases hematoma size and outcomes.

Intraventricular extension worsens prognosis from hydrocephalus pressure.

Early hematoma growth significantly increases death and disability risk.

High blood glucose at presentation worsens outcomes and increases mortality.

Early surgical evacuation improves survival in large cerebellar hemorrhages.

Clinical History

Clinical History:

Collect details including the presenting symptoms, precipitating events, medical and family history to understand clinical history of patients.

Physical Examination

Neurological Examination

Motor Examination

Sensory Examination

Level of Consciousness

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Acute symptoms are:

Headache, vomiting, seizures, hemiparesis, hemisensory loss, aphasia, ataxia

Differential Diagnoses

Blood Dyscrasias and Stroke

Cardioembolic Stroke

Head Injury

Moyamoya Disease

Subdural Empyemaq

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

Treatment Paradigm:

Intracranial hemorrhage therapy emphasizes adjunctive measures for injury minimization and stabilization.

Clinical trials indicated that recombinant factor VIIa administered within 4 hours post-intracerebral hemorrhage limits hematoma growth and improves outcomes.

Early rFVIIa use in head injury patients without systemic coagulopathy may lower contusion enlargement and adverse outcomes.

Fosphenytoin or other anticonvulsants are recommended for seizures, while levetiracetam is effective for children’s prophylaxis.

Antihypertensive treatment study suggests more research on aggressive SBP reduction.

Maintain euvolemia with normotonic fluids for brain perfusion safety.

Use antihypertensives lower blood pressure to prevent hemorrhage.

Acetaminophen reduces fever and headache to prevent neurological injury.

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-non-pharmacological-approach-for-intracranial-hemorrhage

Access to emergency equipment in the form of suction, oxygen, and airway equipment at bedside.

Start enteral feedings promptly and consider nasogastric or percutaneous device placement.

Patient should maintain bedrest during the first 24 hours. Patient should avoid strenuous exertion.

Proper awareness about intracranial hemorrhage should be provided and its related causes with management strategies.

Appointments with neurologist and preventing recurrence of disorder is an ongoing life-long effort.

Use of Antihypertensive agents

Nicardipine:

It is a calcium channel blocker that acts as a potent rapid onset of action and ease of titration.

Use of Osmotic diuretics

Mannitol:

It reduces cerebral edema with help of osmotic forces and decreases blood viscosity.

Use of Analgesic

Acetaminophen:

It works peripherally to block pain impulse generation in CNS.

Use of Anticonvulsants

Fosphenytoin:

It stabilizes neuronal membranes and decreases seizure activity.

Use of Antacids

Famotidine:

It inhibits histamine at H2 receptor of gastric parietal cells to reduce gastric acid secretion.

use-of-intervention-with-a-procedure-in-treating-intracranial-hemorrhage

Consider nonsurgical management for patients with minor deficits or small hemorrhage.

Consider surgery for cerebellar hemorrhage >3 cm and intracerebral hemorrhage with vascular lesions.

Surgical approaches include craniotomy, stereotactic aspiration, and endoscopic evacuation.

use-of-phases-in-managing-intracranial-hemorrhage

In the acute phase, the goal is to prevent hematoma expansion and manage life-threatening complications.

Pharmacologic therapy is effective in the treatment phase as it includes the use of antihypertensive agents, osmotic diuretics, antipyretics, analgesics, anticonvulsants, and antacids.

In supportive care and management phase, patients should receive required attention such as lifestyle modification and surgical interventional procedures.

The regular follow-up visits with the neurologist are scheduled to check the improvement of patients along with treatment response.

Medication

Media Gallary

Content loading

Latest Posts

Intracranial Hemorrhage

Updated : June 6, 2025

Mail Whatsapp PDF Image



Intracranial hemorrhage occurs in brain or meninges. Meningeal hemorrhage includes epidural, subdural, and subarachnoid types.

Intracerebral hemorrhage causes more death and disability than other strokes. Intracerebral hemorrhage causes edema to disrupt brain tissue and dysfunction.

Brain parenchyma displacement can increase intracranial pressure and herniation

It occurs in various brain areas and is classified into multiple types.

Types of Intracranial Hemorrhage are:

Intracerebral Hemorrhage

Subarachnoid Hemorrhage

Epidural Hemorrhage

Subdural Hemorrhage

Intracranial Hemorrhage is dangerous bleeding inside the skull. Ruptured blood vessel causes accumulation of blood in brain.

It increased intracranial pressure damages brain tissue. Blood products cause inflammation, injury to brain cells, and disrupt cerebral autoregulation.

Intracerebral hemorrhage affects 12-15 per 100,000 individuals yearly. Asian countries have higher intracerebral hemorrhage incidence globally.

Over 20,000 Americans die annually from intracerebral hemorrhage, with a 30-day mortality rate of 44%.

Intracerebral hemorrhage occurs more in hypertensive African American populations.

Higher intracerebral hemorrhage rates observed in Asian populations may stem from environmental or genetic factors.

Intracerebral hemorrhage slightly favours males, while cerebral amyloid angiopathy may favour females.

Intracerebral hemorrhage incidence doubles every decade after age 55 until 80 years old.

Hypertensive damage causes most nontraumatic intracerebral hemorrhages.

Cranial trauma causes intracerebral hemorrhage frequently. Blunt head trauma patients on warfarin or clopidogrel face higher intracranial hemorrhage risk.

Rare delayed traumatic intracranial hemorrhage in warfarin patients. Intraventricular hemorrhage occurs in one-third of intracerebral hemorrhage cases due to extension.

Chronic hypertension leads to small vessel vasculopathy with lipohyalinosis and Charcot-Bouchard aneurysms in brain.

The causes of intracranial hemorrhage are:

Vascular Malformations

Tumors

Illicit Drug Use

Vascular disease

Blood disorders

Substance use

Trauma

Infections

Age

Anticoagulation during hemorrhage increases hematoma size and outcomes.

Intraventricular extension worsens prognosis from hydrocephalus pressure.

Early hematoma growth significantly increases death and disability risk.

High blood glucose at presentation worsens outcomes and increases mortality.

Early surgical evacuation improves survival in large cerebellar hemorrhages.

Clinical History:

Collect details including the presenting symptoms, precipitating events, medical and family history to understand clinical history of patients.

Neurological Examination

Motor Examination

Sensory Examination

Level of Consciousness

Acute symptoms are:

Headache, vomiting, seizures, hemiparesis, hemisensory loss, aphasia, ataxia

Blood Dyscrasias and Stroke

Cardioembolic Stroke

Head Injury

Moyamoya Disease

Subdural Empyemaq

Treatment Paradigm:

Intracranial hemorrhage therapy emphasizes adjunctive measures for injury minimization and stabilization.

Clinical trials indicated that recombinant factor VIIa administered within 4 hours post-intracerebral hemorrhage limits hematoma growth and improves outcomes.

Early rFVIIa use in head injury patients without systemic coagulopathy may lower contusion enlargement and adverse outcomes.

Fosphenytoin or other anticonvulsants are recommended for seizures, while levetiracetam is effective for children’s prophylaxis.

Antihypertensive treatment study suggests more research on aggressive SBP reduction.

Maintain euvolemia with normotonic fluids for brain perfusion safety.

Use antihypertensives lower blood pressure to prevent hemorrhage.

Acetaminophen reduces fever and headache to prevent neurological injury.

Neurology

Access to emergency equipment in the form of suction, oxygen, and airway equipment at bedside.

Start enteral feedings promptly and consider nasogastric or percutaneous device placement.

Patient should maintain bedrest during the first 24 hours. Patient should avoid strenuous exertion.

Proper awareness about intracranial hemorrhage should be provided and its related causes with management strategies.

Appointments with neurologist and preventing recurrence of disorder is an ongoing life-long effort.

Neurology

Nicardipine:

It is a calcium channel blocker that acts as a potent rapid onset of action and ease of titration.

Neurology

Mannitol:

It reduces cerebral edema with help of osmotic forces and decreases blood viscosity.

Neurology

Acetaminophen:

It works peripherally to block pain impulse generation in CNS.

Neurology

Fosphenytoin:

It stabilizes neuronal membranes and decreases seizure activity.

Neurology

Famotidine:

It inhibits histamine at H2 receptor of gastric parietal cells to reduce gastric acid secretion.

Neurology

Consider nonsurgical management for patients with minor deficits or small hemorrhage.

Consider surgery for cerebellar hemorrhage >3 cm and intracerebral hemorrhage with vascular lesions.

Surgical approaches include craniotomy, stereotactic aspiration, and endoscopic evacuation.

Neurology

In the acute phase, the goal is to prevent hematoma expansion and manage life-threatening complications.

Pharmacologic therapy is effective in the treatment phase as it includes the use of antihypertensive agents, osmotic diuretics, antipyretics, analgesics, anticonvulsants, and antacids.

In supportive care and management phase, patients should receive required attention such as lifestyle modification and surgical interventional procedures.

The regular follow-up visits with the neurologist are scheduled to check the improvement of patients along with treatment response.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses